Related Experiment Video
Updated: Oct 27, 2025

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
Published on: August 28, 2015
Self-stabilized Pt(IV) amphiphiles by precise regulation of branch length for enhanced chemotherapy
Xiao Kuang1, Yuting Hu1, Dongxu Chi1
1Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.
Abstract:
A surge of platinum(IV) compounds are utilized or investigated in cancer treatment but their therapeutic outcomes have been greatly compromised by remaining adverse effects and limited antitumor performance, attributable to nonspecific distribution and insufficient activation in tumor site. Herein, we designed a series of disulfide bond introduced Pt(IV)-lipid prodrugs with different branch length, all of which are able to self-stabilize into nanomedicine and be activated by high intracellular glutathione (GSH) level. The impact of precise modification of these prodrugs on their assembly stability, pharmacokinetics and cytotoxicity was probed to establish a connection between chemical structure and antiproliferation efficiency. With optimal assembly manner and delivery efficacy, the longest axial branched Pt(IV) prodrug CSS18 exhibited the most impressive therapeutic outcome, providing a potential path to more efficient nanocarriers for chemotherapeutic agents by chemical modulation and, giving insights into the rational design of reduction responsive platinum delivery system.
Insights
Researchers developed new platinum(IV) lipid prodrugs that self-assemble into nanomedicines. These compounds show improved cancer treatment efficacy by activating within tumor cells, offering a promising approach for chemotherapy delivery.
Area of Science:
- Nanomedicine
- Cancer Therapeutics
- Drug Delivery Systems
Background:
- Platinum(IV) compounds are investigated for cancer treatment but face challenges with adverse effects and limited efficacy due to poor tumor targeting and activation.
- Existing platinum-based chemotherapeutics often suffer from nonspecific distribution and insufficient activation at the tumor site, hindering their therapeutic potential.
Purpose of the Study:
- To design and synthesize novel disulfide bond-introduced platinum(IV)-lipid prodrugs with varying branch lengths.
- To investigate the structure-activity relationship of these prodrugs concerning their self-assembly, pharmacokinetics, and cytotoxicity.
- To establish a reduction-responsive platinum delivery system for enhanced cancer therapy.
Main Methods:
- Synthesis of a series of Pt(IV)-lipid prodrugs featuring disulfide bonds and differing axial branch lengths.
- Characterization of prodrug self-assembly into nanomedicines.
- Evaluation of prodrug stability, pharmacokinetics, and in vitro cytotoxicity, particularly in response to intracellular glutathione (GSH) levels.
Main Results:
- The designed Pt(IV)-lipid prodrugs self-stabilized into nanomedicines, demonstrating activation by high intracellular glutathione (GSH) levels.
- Modifications in prodrug structure significantly impacted assembly stability, pharmacokinetics, and cytotoxicity.
- The Pt(IV) prodrug with the longest axial branch (CSS18) showed superior assembly, delivery efficacy, and the most significant therapeutic outcome.
Conclusions:
- Chemical modulation of Pt(IV)-lipid prodrugs enables the rational design of efficient, self-stabilizing nanocarriers.
- The developed reduction-responsive platinum delivery system, exemplified by CSS18, offers a promising strategy for improving cancer chemotherapeutic outcomes.
- This study provides insights into designing advanced nanomedicines for targeted and effective cancer treatment.
Related Concept Videos
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

